PFAS Create Unique Blood Signatures as Body Transforms Forever Chemicals

Scientists discover PFAS compounds create unique chemical fingerprints in blood as they transform in the human body. New detection methods…

Submit Your Paper to GMJ

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.

Georgia Must Prioritize Health Worker Safety as Strategic National Goal

Healthcare worker safety in Georgia requires urgent strategic attention as the country builds a resilient health system. The COVID-19 pandemic…

AI Tool Detects Silent Bone Loss from Routine Chest X-rays Before Fractures Strike

New AI technology can detect early bone loss from routine chest X-rays, potentially identifying millions of at-risk patients who fall…

Ethiopia Integrates Oxytocin into Vaccine Cold Chain to Prevent Maternal Deaths

Ethiopia successfully integrated oxytocin storage into its vaccine cold chain system through a structured evidence-based policy process. The initiative addresses…

Paracetamol Poisoning Study Reveals High Risk of Repeated Attempts and Long-term Mortality

A 15-year Australian study of 12,047 paracetamol poisoning cases reveals that while severe liver injury is rare (4.7%), nearly a…

Open-Source AI Tool Improves Pancreatic Cancer Vascular Invasion Assessment Across Multiple Centres

New open-source AI system achieves 94.2% accuracy in pancreatic cancer vascular invasion assessment across multiple medical centres. The freely available…

Ecuador study reveals triple burden of malnutrition affecting 73% of children

New research reveals that 73.3% of Ecuadorian children under 5 experience overlapping forms of malnutrition, with indigenous children facing the…

Rural Georgia Community Challenges ICE Detention Center Over Healthcare Capacity Concerns

Social Circle, Georgia challenges federal plans for ICE detention facility, citing concerns about overwhelming the rural community's limited healthcare infrastructure.…

BioNTech-Pfizer Bispecific Antibody Shows Promise in Advanced Lung Cancer at ASCO 2026

BioNTech and Pfizer's experimental bispecific antibody BNT327 showed promising activity in advanced lung cancer patients at ASCO 2026. The dual-pathway…

GMJ BriefsView all →